Kaken Pharmaceutical stock reports a strong first quarter
Published on 10/07/2026 at 01:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKaken Pharmaceutical stock (ISIN JP3207000005) was last at JPY 3,770 on the Tokyo Stock Exchange on October 6, 2026 at 3:30 p.m. JST, up 0.40 percent from the prior close. The company delivered a strong first quarter, with the earnings figures now setting the main context for the shares.
First quarter delivers a sharp profit signal
For Q1 FY27, Kaken Pharmaceutical reported revenue of JPY 30.15 billion and net income of JPY 8.44 billion, according to Yahoo Finance in its October 2, 2026 update. The figures cover the company's first quarter of fiscal 2027 and give investors a concrete measure of the earnings contribution entering the rest of the year.
The comparison with the full-year plan is unusually direct. Kaken's FY2027 company forecast calls for revenue of JPY 89.9 billion and net income of JPY 6.5 billion, figures listed by Minkabu on September 26, 2026, so first-quarter net income already exceeded the annual forecast.
Consensus target remains above the price
Analyst sentiment was neutral on September 26, 2026, with one Buy rating and three Hold ratings among four analysts. Investing.com reported an average 12-month target of JPY 4,575, with a high target of JPY 5,600 and a low target of JPY 4,000.
Against the October 6 last price of JPY 3,770, the average target lies 21.4 percent above the stock. That gap puts the Q1 profit result beside a more measured analyst stance, rather than a uniform bullish call.
Next results date is November 9
Kaken's next earnings date is scheduled for November 9, 2026, according to Yahoo Finance. The next report will show whether the first-quarter earnings concentration is followed by further operating progress under the fiscal-year plan.
Stock trades below its yearly high
Kaken was last at JPY 3,770 on the Tokyo Stock Exchange on October 6, 2026 at 3:30 p.m. JST. Its 52-week range was JPY 3,540 to JPY 4,445, leaving the stock 15.2 percent below the upper end of that range.
Kaken Pharmaceutical stock facts
- Company: Kaken Pharmaceutical Co., Ltd.
- ISIN: JP3207000005
- Ticker: 4521
- Trading venue: Tokyo Stock Exchange Prime Market
- Price (as of October 6, 2026, 3:30 p.m. JST): JPY 3,770
- Market capitalization: JPY 142.8 billion (as of October 6, 2026)
- 52-week range: JPY 3,540-4,445 (as of October 6, 2026)
- Sector / Industry: Healthcare / Pharmaceuticals
- Index membership: TOPIX Small 1
Upcoming dates for Kaken Pharmaceutical stock
- November 9, 2026: Earnings report
